EFFECTOR THERAPEUTICS, INC.

Profile

Company Names

EFFECTOR THERAPEUTICS, INC.

Addresses

11180 ROSELLE STREET, SUITE A, SAN DIEGO, CA 92121

11180 ROSELLE STREET, SAN DIEGO, CA 92121

Phone Numbers

858-442-4861

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$129,428,616.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-04-30 
$20,422,514.00 
$21,800,011.00 
$1,377,497.00 
Equity 
3
2017-07-19 
$16,800,008.00 
$38,600,020.00 
$21,800,012.00 
Equity 
2
2015-12-11 
$56,000,005.00 
$56,000,005.00 
$0.00 
Equity 
1
2013-05-15 
$36,206,089.00 
$56,983,867.00 
$20,777,778.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEREMY 
 
BARTON, M.D. 
EXECUTIVE OFFICER
EFFECTOR THERAPEUTICS, INC.
CAROL 
G. 
GALLAGHER, PHARM.D. 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
SIMEON 
 
GEORGE 
DIRECTOR
SEMPRUS BIOSCIENCES CORP   |  GENOCEA BIOSCIENCES, INC.   |  HTG MOLECULAR DIAGNOSTICS INC   |  AUXOGYN INC   |  EFFECTOR THERAPEUTICS, INC.   |  HTG MOLECULAR DIAGNOSTICS, INC   |  AUXOGYN, INC.   |  PRINCIPIA BIOPHARMA INC.   |  PROGYNY, INC.   |  TP THERAPEUTICS, INC.   |  CRISPR THERAPEUTICS AG   |  SR ONE CO-INVEST I, LLC   |  SIMCHA THERAPEUTICS HOLDING COMPANY, LLC   |  ADARX PHARMACEUTICALS, INC.   |  SR ONE CAPITAL FUND II-B, LP   |  SR ONE CAPITAL FUND II-A, LP   |  AVENZO THERAPEUTICS, INC.   |  REZO THERAPEUTICS, INC.   |  SR ONE CAPITAL FUND III, LP
SIMEON 
J. 
GEORGE, M.D. 
DIRECTOR
PRINCIPIA BIOPHARMA INC.   |  EFFECTOR THERAPEUTICS, INC.
MARKUS 
 
GOEBEL 
DIRECTOR
TRELLIS BIOSCIENCE INC   |  LIGOCYTE PHARMACEUTICALS INC   |  SORBENT THERAPEUTICS INC   |  EFFECTOR THERAPEUTICS, INC.   |  RA PHARMACEUTICALS, INC.   |  MERGANSER BIOTECH, INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  E-SCAPE BIO, INC.
MARKUS 
 
GOEBEL, M.D., PH.D. 
DIRECTOR
LIGOCYTE PHARMACEUTICALS INC   |  EFFECTOR THERAPEUTICS, INC.
KEN 
 
HAAS 
DIRECTOR
INTELLIKINE, INC.   |  GYNESONICS, INC   |  ZOGENIX INC   |  PATHWORK DIAGNOSTICS INC   |  EFFECTOR THERAPEUTICS, INC.   |  SONITUS MEDICAL INC
KENNETH 
 
HAAS, J.D. 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
ELAINE 
 
JONES, PH.D. 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.   |  GRITSTONE BIO, INC.
MAHA 
 
KATABI 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  AEROVATE THERAPEUTICS, INC.   |  VERA THERAPEUTICS, INC.   |  GYROSCOPE THERAPEUTICS LTD   |  QUANTA THERAPEUTICS, INC.   |  SOFINNOVA VENTURE PARTNERS XI, L.P.   |  RAYZEBIO, INC.   |  MAREA THERAPEUTICS, INC.   |  SOFINNOVA VENTURE PARTNERS XII, L.P.   |  STAR THERAPEUTICS LLC
MAHA 
 
KATABI, PH.D. 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
STEFAN 
 
LARSON, PH.D. 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
LAURENCE 
 
LASKY 
DIRECTOR
CALITHERA BIOSCIENCES, INC.   |  EFFECTOR THERAPEUTICS, INC.   |  RIBON THERAPEUTICS, INC.   |  REVOLUTION MEDICINES, INC.
LAURENCE 
 
LASKY, PH.D. 
DIRECTOR
COLUMN GROUP II, LP   |  EFFECTOR THERAPEUTICS, INC.
DAVID 
 
MAKI 
DIRECTOR
PULMATRIX INC   |  PULMATRIX OPERATING COMPANY, INC.   |  PULMATRIX, INC.   |  ALTITUDE LIFE SCIENCE VENTURES SIDE FUND II, L.P.   |  EFFECTOR THERAPEUTICS, INC.   |  HDP I REIT LLC   |  HEITMAN CORE REAL ESTATE DEBT INCOME TRUST, L.P.   |  HEITMAN CREDIT REIT, LLC   |  ALTITUDE LIFE SCIENCE VENTURES SIDE FUND III, L.P.   |  APFC HCF HOLDINGS REIT LLC   |  HEITMAN GLOBAL REAL ESTATE REIT LLC   |  HEITMAN REAL ESTATE DEBT PARTNERS III, L.P.   |  HEITMAN REAL ESTATE DEBT PARTNERS III-A, L.P.   |  HEITMAN REAL ESTATE DEBT PARTNERS III-BLOCKER, L.P.   |  HDP III REIT INVESTMENTS LLC
DAVID 
 
MAKI, J.D. 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
ALANA 
 
MCNULTY 
EXECUTIVE OFFICER
EFFECTOR THERAPEUTICS, INC.
DENIS 
 
PATRICK, PH.D. 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
JONATHAN 
 
ROOT 
DIRECTOR
SEQUENT MEDICAL, INC.   |  LUTONIX INC   |  INCEPTUS NEWCO1 INC.   |  ONCOMED PHARMACEUTICALS INC   |  INARI MEDICAL, INC.   |  OMADA HEALTH, INC.   |  EFFECTOR THERAPEUTICS, INC.   |  RIBON THERAPEUTICS, INC.   |  ROUTE 92 MEDICAL, INC.   |  AIS VGP-6, LLC   |  CLEAVE BIOSCIENCES, INC.   |  NUVAIRA, INC.   |  HEALTHJOY, INC.   |  OKAMI MEDICAL, INC.   |  EDGEWISE THERAPEUTICS, INC.   |  SWOOP.COM, INC   |  SILVERBACK THERAPEUTICS, INC.   |  EL CAMINO REAL MEDICAL, INC.   |  HIGHWAY 1 MEDICAL, INC.   |  CARLSMED, INC.   |  SURGICAL SAFETY TECHNOLOGIES INC.   |  SPARROW PHARMACEUTICALS, INC.
JONATHAN 
D. 
ROOT, M.D. 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
JOHN 
W. 
SMITHER 
DIRECTOR
ACHAOGEN INC   |  EFFECTOR THERAPEUTICS, INC.
STEPHEN 
F. 
WORLAND, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
EFFECTOR THERAPEUTICS, INC.
STEPHEN 
T. 
WORLAND, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
EFFECTOR THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-05-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-04-30 
2017-07-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-07-19 
2016-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-11 
2015-12-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-11 
2015-07-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-15 
2014-08-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-15 
2013-05-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#